D-0605-2021 Class III Terminated

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA drug recall D-0605-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 28, 2021 and is designated Class III. Reason for recall: Temperature Abuse: Product exposed to temperature outside specified limits. The recall status is terminated (terminated Sep 17, 2021). Affected quantity: 672 cases.

Recall details

Product Type
Drugs
Report Date
Jun 16, 2021
Initiation Date
Apr 28, 2021
Termination Date
Sep 17, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
672 cases

Product description

DELFLEX Peritoneal Dialysis Solution with 2.5 % Dextrose, Low Magnesium, Low Calcium, packaged in a) 3000 mL 2 packs (NDC 49230-0209-23), b) 3000 mL (NDC 49230-209-30) and c) 5000 mL (NDC 49230-209-50) Rx only, Fresenius Medical Care NA Waltham, MA 02451

Reason for recall

Temperature Abuse: Product exposed to temperature outside specified limits.

Distribution pattern

Nationwide within the United States

Code information

Lot #: a) 20PU03043, Exp. Date June 2022; b) 20SU03036, Exp. date July 2022; c) 20Su07012, Exp. date July 2022; 21AU07021, 21AU02037, 21AU01007, 21AU01006, 21AU01019, Exp. date August 2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0605-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0605-2021. Report a data issue: hello@regdatalab.com.